Kathy A. Keith

1.8k total citations
47 papers, 1.5k citations indexed

About

Kathy A. Keith is a scholar working on Epidemiology, Virology and Genetics. According to data from OpenAlex, Kathy A. Keith has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 24 papers in Virology and 13 papers in Genetics. Recurrent topics in Kathy A. Keith's work include Herpesvirus Infections and Treatments (26 papers), Poxvirus research and outbreaks (22 papers) and Cytomegalovirus and herpesvirus research (14 papers). Kathy A. Keith is often cited by papers focused on Herpesvirus Infections and Treatments (26 papers), Poxvirus research and outbreaks (22 papers) and Cytomegalovirus and herpesvirus research (14 papers). Kathy A. Keith collaborates with scholars based in United States, Ukraine and United Kingdom. Kathy A. Keith's co-authors include Earl R. Kern, Debra C. Quenelle, Mark N. Prichard, James R. Beadle, Karl Y. Hostetler, Caroll B. Hartline, Emma A. Harden, Dennis E. Hruby, Robert Jordan and Paul F. Torrence and has published in prestigious journals such as Journal of Virology, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Kathy A. Keith

45 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathy A. Keith United States	20	766	572	507	395	270	47	1.5k
Jochen Bodem Germany	24	435 0.6×	674 1.2×	739 1.5×	180 0.5×	632 2.3×	68	2.2k
Jonathan A. Coates Australia	19	359 0.5×	264 0.5×	448 0.9×	390 1.0×	369 1.4×	40	1.1k
David J. Clanton United States	22	235 0.3×	560 1.0×	684 1.3×	193 0.5×	455 1.7×	37	1.4k
James Merson United States	18	521 0.7×	400 0.7×	638 1.3×	152 0.4×	490 1.8×	27	1.4k
Yvette Hénin France	23	309 0.4×	512 0.9×	650 1.3×	223 0.6×	506 1.9×	51	1.7k
Kelli Kuhen United States	24	289 0.4×	292 0.5×	796 1.6×	709 1.8×	376 1.4×	38	2.2k
Nicolas Tarbouriech France	25	671 0.9×	304 0.5×	613 1.2×	79 0.2×	319 1.2×	43	1.7k
Zheng Yin China	21	232 0.3×	261 0.5×	650 1.3×	215 0.5×	681 2.5×	41	2.2k
Christian G. Noble Singapore	25	269 0.4×	330 0.6×	914 1.8×	127 0.3×	831 3.1×	35	2.5k
Neşe Kurt Yılmaz United States	26	313 0.4×	546 1.0×	925 1.8×	203 0.5×	883 3.3×	71	2.0k

Countries citing papers authored by Kathy A. Keith

Since Specialization

Citations

This map shows the geographic impact of Kathy A. Keith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy A. Keith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy A. Keith more than expected).

Fields of papers citing papers by Kathy A. Keith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy A. Keith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy A. Keith. The network helps show where Kathy A. Keith may publish in the future.

Co-authorship network of co-authors of Kathy A. Keith

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy A. Keith. A scholar is included among the top collaborators of Kathy A. Keith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy A. Keith. Kathy A. Keith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keith, Kathy A., et al.. (2024). A ProTide of AZT Shows Activity Against Human Papillomaviruses. ChemMedChem. 19(8). e202300661–e202300661.

Shablykin, Oleh, Kathy A. Keith, Emma A. Harden, et al.. (2023). In vitro activity of novel 4-iminohydantoin sulfamide derivatives against human cytomegalovirus. Chemical Papers. 78(1). 133–140. 2 indexed citations

Kovalishyn, Vasyl, Kathy A. Keith, Emma A. Harden, et al.. (2021). Design of new imidazole derivatives with anti-HCMV activity: QSAR modeling, synthesis and biological testing. Journal of Computer-Aided Molecular Design. 35(12). 1177–1187. 11 indexed citations

Hartline, Caroll B., et al.. (2018). A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesviruses. Antiviral Research. 159. 104–112. 25 indexed citations

Keith, Kathy A., Caroll B. Hartline, Terry L. Bowlin, & Mark N. Prichard. (2018). A standardized approach to the evaluation of antivirals against DNA viruses: Polyomaviruses and lymphotropic herpesviruses. Antiviral Research. 159. 122–129. 12 indexed citations

Beadle, James R., R. Mark L. Buller, Mark N. Prichard, et al.. (2011). Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine. Bioorganic & Medicinal Chemistry. 19(9). 2950–2958. 15 indexed citations

Schormann, Norbert, Charnell I. Sommers, Mark N. Prichard, et al.. (2011). Identification of Protein-Protein Interaction Inhibitors Targeting Vaccinia Virus Processivity Factor for Development of Antiviral Agents. Antimicrobial Agents and Chemotherapy. 55(11). 5054–5062. 18 indexed citations

Keith, Kathy A., Emma A. Harden, Rachel Gill, et al.. (2010). Efficacy of N-methanocarbathymidine Against Herpes Simplex Virus is Cell Cycle Dependent. Antiviral Research. 86(1). A58–A58. 2 indexed citations

Valiaeva, Nadejda, Mark N. Prichard, R. Mark L. Buller, et al.. (2009). Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses. Antiviral Research. 84(3). 254–259. 16 indexed citations

10.

Keith, Kathy A., S K Sanders, K.P. Tiwari, et al.. (2009). Combinations of 5-Iodo-4′-thio-2′-deoxyuridine and ST-246 or CMX001 Synergistically Inhibit Orthopoxvirus Replication In Vitro. Antiviral Research. 82(2). A33–A34. 1 indexed citations

11.

Prichard, Mark N., Earl R. Kern, Debra C. Quenelle, et al.. (2008). Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine. Virology Journal. 5(1). 39–39. 11 indexed citations

12.

Quenelle, Debra C., Deborah J. Collins, Kathy A. Keith, et al.. (2007). Effect of Oral Treatment with Hexadecyloxypropyl-[( S )-9-(3-Hydroxy-2- Phosphonylmethoxypropyl)Adenine] [( S )-HPMPA] or Octadecyloxyethyl-( S )-HPMPA on Cowpox or Vaccinia Virus Infections in Mice. Antimicrobial Agents and Chemotherapy. 51(11). 3940–3947. 31 indexed citations

13.

Quenelle, Debra C., Mark N. Prichard, Kathy A. Keith, et al.. (2007). Synergistic Efficacy of the Combination of ST-246 with CMX001 against Orthopoxviruses. Antimicrobial Agents and Chemotherapy. 51(11). 4118–4124. 105 indexed citations

14.

Fan, Xuesen, Xinying Zhang, Longhu Zhou, et al.. (2006). A pyrimidine–pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity. Bioorganic & Medicinal Chemistry Letters. 16(12). 3224–3228. 67 indexed citations

15.

Prichard, Mark N., Angela D. Williams, Kathy A. Keith, Emma A. Harden, & Earl R. Kern. (2006). Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs. Antiviral Research. 71(1). 1–6. 17 indexed citations

16.

Quenelle, Debra C., Kathy A. Keith, & Earl R. Kern. (2006). In vitro and in vivo evaluation of isatin-β-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Research. 71(1). 24–30. 114 indexed citations

17.

Schneller, Stewart W., et al.. (2005). The 4′,4′-difluoro analog of 5′-noraristeromycin: A new structural prototype for possible antiviral drug development toward orthopoxvirus and cytomegalovirus. Bioorganic & Medicinal Chemistry. 13(14). 4443–4449. 17 indexed citations

18.

Keith, Kathy A., Michael J. M. Hitchcock, William A. Lee, Antonı́n Holý, & Earl R. Kern. (2003). Evaluation of Nucleoside Phosphonates and Their Analogs and Prodrugs for Inhibition of Orthopoxvirus Replication. Antimicrobial Agents and Chemotherapy. 47(7). 2193–2198. 54 indexed citations

19.

Quenelle, Debra C., Kathy A. Keith, Karen Dunleavy, et al.. (1997). Evaluation of anti-AIDS drugs in conventional mice implanted with a permeable membrane device containing human T cells infected with HIV. Antiviral Research. 35(2). 123–129. 2 indexed citations

20.

Keith, Kathy A., et al.. (1990). Stage-specific cuticular proteins of Ostertagia circumcincta and Ostertagia ostertagi. International Journal for Parasitology. 20(8). 1037–1045. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact